Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic

Document Viewer

Share this page:

Title

Subject

Treatment & Care

Description

EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.

Creator

U.S. Food and Drug Administration

Date Last Updated (Year-Month-Day)

2020-04-30

Citation

Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/137522/download

Download Patients Fact Sheet directly: https://www.fda.gov/media/137521/download

Download other documents directly:

Instructions for Use, Bloodline/ Tubing (83KB)

Instructions for Use, UltraFlux (147KB)

Instructions for Use, multiFiltratePRO (15.07MB)

Summary of Product Characteristics (SmPC) (308KB)

Instructions for Use, MultiPlus (110KB)

URL

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs

Click for External Resource

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs

*This link may link to a hosted zip file or an external resource. Zip files will download automatically. Other links will open in a new window.

Files for download

Item Type:

Guide

Collection

Implement

Citation for this page

U.S. Food and Drug Administration, “Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic,” NETEC Repository, accessed November 23, 2020, https://repository.netecweb.org/items/show/1405.

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.